Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$49,609,000
+$18,324,890 QoQ
Shares Held
2,660,000
+1.4% QoQ
Ownership
1.87%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#15
of 216 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EVENTIDE ASSET MANAGEMENT, LLC holds $1,774,593,873 across 55 Biotechnology names. TRVI ranks #11 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,248,389 | $146,148,900 | |
| 2 | ARGX |
Argenx SE
|
125,668 | $116,591,000 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
2,111,410 | $116,127,550 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
1,380,219 | $80,232,130 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
316,820 | $77,548,031 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,380,261 | $77,391,234 | |
| 7 | INSM |
INSMED Inc
|
583,665 | $62,230,362 | |
| 8 | BLTE |
Belite Bio, Inc
|
390,829 | $60,181,803 |
All Filings in TRVI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,609,000 | 2,660,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $31,284,110 | 2,622,306 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $32,831,271 | 2,622,306 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,639,114 | 1,381,324 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,555,842 | 1,381,324 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||